Psykey, Inc. (CEOS) 是一家上市公司 屬於 醫療保健 板塊，經營於 Medical - Instruments & Supplies 產業. 公司總部位於 Toronto, ON, 加拿大. 現任CEO為 Michael Maher.
CEOS 擁有 IPO日期為 2006-02-14, 6 名全職員工, 在 Other OTC, 市值為 $124.89K.
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.
